BEERs For the Elderly

Size: px
Start display at page:

Download "BEERs For the Elderly"

Transcription

1 BEERs For the Elderly February 2008 Presented by:carla Ambrosini Seniors First Clinic Pharmacist 12/05/2008 1

2 Objectives To highlight the overall health care impact of drug related adverse reactions and events. To introduce the Beers Criteria as a tool to help identify potentially inappropriate medication use in older adults Educate about other risky drugs classes Educate on Medication that can increase Falls List Medications that can cause delirum 12/05/2008 2

3 Definitions Adverse Drug Reaction (ADR) Any noxious, unintended and undesired effects of a drug, which occurs at doses used in humans for prophylaxis, diagnosis or therapy. WHO Definition Adverse Drug-Related Event ADR in addition to medication errors (errors in prescribing, dispensing, patient adherence and monitoring). 12/05/2008 3

4 Definitions.. Polypharmacy concomitant use of multiple drugs administration of more medications that are indicated clinically THE KEY Ensure medication are clinically indicated and not necessarily the number of medications 12/05/2008 4

5 Drug-Related Problems Untreated Indication Improper Drug Selection Sub therapeutic Dosage Failure to Receive Drug Overuse Adverse Drug Reaction Drug Interactions Polypharmacy (drugs Prescribed without an indication) 12/05/2008 5

6 Drug Related Mortality:CBC Findings Seniors account for 44% of all reported adverse reactions causing death even though they make up 13% of the population 16,000 Canadian Seniors died from an adverse related events during the five years between (3,300/yr) 12/05/2008 6

7 Drug Related Morbidity Majority of the Literature focus is on Adverse Drug Reactions and visits to the ER 28% of ER visits are drug related 27% resulted in hospital admissions 38-70% preventable Cost $576/EDV and $4834/admission (US$) 2004/2005 FHA data 403,000 ER Visits therefore 113,064 due to drug related problems, 27,135 admissions, 79,145 were preventable. 12/05/2008 7

8 Why are Elderly more Vulnerable to Side Effects Drugs are less well handled due to age related changes Inappropriate drugs and doses are taken Polypharmacy Multiple and Chronic Health Conditions Plus intermittent acute health conditions Decreased Vision, Hearing and cognition 12/05/2008 8

9 The Beers List Developed by an expert panel (geriatricians and pharmacologists) and led by Gerontologist Mark H. Beers in 1991 First Published in 1997 and updated most recently in Used as a guideline/reference for potentially inappropriate medication use in older adults Does NOT substitute for clinical judgment, still need to weigh risk vs. benefit 12/05/2008 9

10 The BEERs LIST Two tables were developed Table 1: List 48 individual drugs or drug classes that should be avoided in persons 65 or older because they are ineffective or pose unnecessarily high risk for older persons. Table 2: lists medication that should not be used in older persons known to have a specific medical condition, 20 disease/conditions are listed 12/05/

11 CBC findings 1/3 of all reported senior deaths were taking at one of the drugs on the BEERs list 1 in 20 reported seniors deaths were suspected to have been caused by BEERs drugs that had no conditions, meaning that they should not have been prescribed. 1 in 14 reported seniors deaths were suspected to have been caused by BEERs conditional list. 12/05/

12 Diseases and Conditions Identified by Beers Arrhythmias Tricyclic Antidepressants (imipramine, amitriptyline) not used due to proarrhythmic effects and QT changes (HIGH) Anorexia and Malnutrion CNS Stimulants:Methylphenidate (Ritalin) and Fluoxetine (Prozac) not used due to appetite suppressing effects (HIGH) 12/05/

13 Diseases. Bladder Outflow Obstruction Anticholinergics, antihistamines, GI antispasmodics, muscle relaxants, oxybutynin (Ditropan), Flavoxate (Urispas),TCA, decongestants and tolterodine (Detrol) not used as it may cause decrease in urinary flow and lead to urinary retention. (HIGH) 12/05/

14 Diseases Cognitive Impairment Barbitutuates, anticholingergics, antispasmodics, CNS Stimulants concern due CNS altering effects (HIGH) COPD Long acting BZD s (diazepam, Valium), Beta Blockers (propranolol) concern may exacerbate or cause respiratory depression (HIGH) 12/05/

15 Diseases Depression Long Term BDZ, Methyldopa, Propranolol concern that may produce or exacerbate depression (HIGH) Heart Failure Disopyramide (Rythmodan) potential to promote fluid retention (HIGH) 12/05/

16 Diseases.. Blood Clotting disorders or on AC NSAID s, ASA, Clopidogrel (Plavix), Ticlopidine (Ticlid) not used as may increase INR, prolong clotting time, inhibit platelet aggregation causing increased bleeding potential (HIGH) Chronic Constipation CA Channel Blockers (Adalat, Isoptin), Anticholingerics, TCA concern may exacerbate constipation (LOW) 12/05/

17 Diseases. Hypertension Pseudephedrine, diet pills, may produce increase in Blood pressure (HIGH) Gastric and Duodenal Ulcers NSAIDS and ASA (>325mg) may exacerbate existing ulcers or produce new ulcers (HIGH) 12/05/

18 Diseases.. Insomnia Decongestants, Theophylline, Ritalin, MAOI s may produce CNS stimulant effects (HIGH) Obesity Olanzapine (Zyprexa) increase appetite and cause further weight gain (LOW) 12/05/

19 Diseases.. Seizure or Epilepsy or Seizure Disorder Clozapine, Chlopromazine, Bupropion (Wellbutrin) may lower seizure thresholds (HIGH) Parkinson s Disease Metoclopramide and conventional Antipsychotics can worsen PD due to antidopaminergic/cholinergic effects (HIGH) 12/05/

20 Diseases. Syncope or Falls BDZ (all), TCA s may produce poor coordination, impaired motor function, syncope and additional falls (HIGH) Stress Incontinence Alpha Blockers (Prazosin, Terazosin) TCA, BDZ s (long acting) may produce polyuria and worsening of incontinence (HIGH) 12/05/

21 Drugs Seniors Should Avoid Benzodiazepines (high) Amiodarone: increase QT, poor efficacy TCA s (HIGH) Amphetamines (HIGH) Barbiturates (HIGH) Belladonna Alkaloids (Bentylol, Buscopan, (HIGH) 12/05/

22 Drugs. Bisacodyl (HIGH) Cascara (HIGH) Chlorpheniramine and Diphenydramine (Benadryl) (HIGH) Cimetidine (LOW) Clonidine (LOW) Cyclobenzaprine (HIGH) 12/05/

23 Drugs Methocarbamol (Robaxin etc) HIGH Methyldopa HIGH Mineral Oil (HIGH) Naproxen (HIGH) Nitrofurantoin (HIGH) Oxybutynin (HIGH) Proxyphene (Darvon) LOW Ticlopidine (HIGH) 12/05/

24 Other High Risk Drug Classes Antibiotics (ADR,GI effects, allergic reactions, compliance, wrong drug, Drug interactions) Anticoagulants (Warfarin) Digoxin Diuretics Hypoglycemic Agents (Insulin) NSAIDs (60-70% of all drug events) 12/05/

25 Drug Interactions Hospitalizations within 1 Week of Drug Initiation of ABX 10% to 20% more likely. Some Examples: Glyburide-Cotrimoxazole (hypoglycemia) Glyburide-Amoxicillin Digoxin-Clarithyromycin Digoxin-Cefuroxime ACEI-K sparing Diuretics REMEMBER INTERACTIONS WITH ABX 12/05/

26 Top Ten Drug Interactions in Long Term Care Warfarin & NSAIDS Warfarin & Sulfa drugs Warfarin & Macrolides Warfarin & Quinolones Warfarin & Phenytoin ACEI & Potassium supplements ACEI & Spironolactone Digoxin & Amiodarone Digoxin & Verapamil Theophylline & Quinolones 12/05/

27 Medication Non-Adherence Common problem (Dipiro 2005): - Meta-analysis (Sullivan): rate of hospital admissions due to non-adherence of all ages was 5.5% - Col et al: 11% of elderly patient admissions resulted from nonadherence - Gurwitz et al: 21 % of preventable ADRs in elderly outpatients were due to errors in patient adherence 12/05/

28 Medication Non-Adherence :Reasons Forgetfulness Hearing or visual problems Inability to understand how to take medications or side effects to watch for. actual or fear of side-effects inability to physically take medications (can t open vials or swallow large tablets). 12/05/

29 Delirium and Medications Can cause hospitalization or can happen during hospitalization Drug induced delirium rate = 12-39% Best treatment is PREVENTION 12/05/

30 Delirium Management Avoid drugs that can precipitate delirium: High risk: opioid analgesics - meperidine antiparkinsonian agents (esp. anticholingerics) Benzodiazipines Centrally-acting agents Corticosteroids Lithium Anticholinergics Diphenhydramine Dimenhydrinate Medium risk: alphablockers antiarrhymics e.g. lidocaine) Antipsychotic s Beta blockers Digoxin NSAIDs Postganglioni c sympathetic blockers Low risk: ACEI Antiasthmatics (aminophylline) antibacterials (quinolones, cepahlosporins, high dose penicillins) anticonvulsants (primidone and phenobarbital) Calcium channel blocker diuretics H2- antogonists 12/05/

31 Falls and Medications Medications linked to falls: Stronger evidence: Psychotropic medications Antidepressants Antipsychotics Benzodiazepines Weaker or conflicting evidence: Cardiovascular drugs Opioids and NSAIDs Hypoglycemic Number of medications 12/05/

32 How To Avoid Drug Related Problems In The Elderly Prescribe medications only for appropriate reasons Avoid inappropriate drugs (BEERs List) Use appropriate doses Start Low and Go Slow Monitor closely for efficacy and side effects Discontinue medications when no longer needed 12/05/

33 How To Avoid Drug Related Problems In The Elderly Screen for medication interactions Screen for high risk patients Screen for omission of treatment Estimate renal & hepatic function Avoid drugs with anticholinergic effects Choose drugs with a proven track record Maximize medication adherence 12/05/

34 Website rugs/beers _table more.html 12/05/

35 Questions? 12/05/

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria

More information

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics

More information

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse

More information

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney

More information

Safe Medication Use. Holly Divine, PharmD, CGP, CDE. University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science

Safe Medication Use. Holly Divine, PharmD, CGP, CDE. University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science Safe Medication Use in the Older Adult Holly Divine, PharmD, CGP, CDE Associate Professor University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science Objectives Know the principles

More information

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day

More information

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE I have no financial conflict of interest to disclose. Lacey Charbonneau, Pharm.D. PGY-1 Community Practice Resident Baptist Medical

More information

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace Aging and Geriatric Assessment Page 1 Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace I. Aging A. Demographics Age 65+ population 3.1 million 1900 31.2 million

More information

Geriatric Pharmacology

Geriatric Pharmacology Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological

More information

Prescribing and Pharmacokinetic Considerations in the Elderly

Prescribing and Pharmacokinetic Considerations in the Elderly Prescribing and Pharmacokinetic Considerations in the Elderly Melanie A. Dodd, Pharm.D., Ph.C., BCPS Associate Professor of Pharmacy in Geriatrics College of Pharmacy The University of New Mexico OBJECTIVES

More information

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of

More information

Chitra Fernando, MD March 18, 2008

Chitra Fernando, MD March 18, 2008 Chitra Fernando, MD March 18, 2008 Definition Statistics Risk factors Why older adults are more prone to ADE Manifestations Inappropriate medications for older adults What can be done to minimize adverse

More information

STOPP and START criteria October 2011

STOPP and START criteria October 2011 # START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which

More information

STOPP START Toolkit Supporting Medication Review in the Older Person

STOPP START Toolkit Supporting Medication Review in the Older Person STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,

More information

Medication Use in Older Adults

Medication Use in Older Adults Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division

More information

Pitfalls in Pharmacotherapy of Geriatrics

Pitfalls in Pharmacotherapy of Geriatrics Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD) Case Study An 85 year old female with a history of atrial fibrillation, stroke, dementia, and hypertension, who is receiving chronic

More information

Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research

Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Home Resources Potentially Inappropriate Medication Use in Older Adults 2015 Resources Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Drugs and Categories of Drugs What these

More information

20.9 15.4 3.1 0.1 0.2 0.2 0.3 0.4 0.6 0.9 1.5 2.2 9.6 6.1 7.3 4.2 1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050 All Ages Age 65+ Age 85+ Female 50.9% Male 49.1% Female

More information

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)

More information

Pharmaceutical Care for Geriatrics

Pharmaceutical Care for Geriatrics Continuing Professional Pharmacy Development Program Pharmaceutical Care for Geriatrics Presented by: Alla El-Awaisi; MPharm, MRPharmS, MSc Event Organizer: Dr. Nadir Kheir; PhD Disclaimer: PRESENTING

More information

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis

More information

Polypharmacy: Guidance for Prescribing in Frail Adults

Polypharmacy: Guidance for Prescribing in Frail Adults Polypharmacy: Guidance for Prescribing in Frail Adults Why is reviewing polypharmacy important? Medication is by far the most common form of medical intervention. Four out of five people aged over 75 years

More information

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Chinenye Emereole, Pharm.D. Clinical Pharmacist Hospice Pharmacy Solutions Objectives Assess and identify hospice patients who

More information

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region Risks Of Polypharmacy Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region What is Polypharmacy? Polypharmacy means many drugs. In practice, polypharmacy refers to the use of more medication

More information

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in This Presentation Medications and Falls Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS A fall is an event which results in a person coming to rest inadvertently on the ground or floor

More information

Neuro Basics SLO Practice (online) Page 1 of 5

Neuro Basics SLO Practice (online) Page 1 of 5 Neuro Basics SLO Practice (online) Page 1 of 5 1) Biogenic amines include ACh, NE, EPI and? a) Melatonin b) Dopamine c) Serotonin d) Histamine e) All of the neurotransmitters listed are biogenic amines.

More information

An approach to prescribing in the elderly. Preamble

An approach to prescribing in the elderly. Preamble An approach to prescribing in the elderly Dr K Outhoff Preamble Advances in medical technology, surgical procedures, medical practice and innovative drug development An increasing proportion of the population

More information

Chronic Obstructive Pulmonary Disease (COPD) Care Management Assessment

Chronic Obstructive Pulmonary Disease (COPD) Care Management Assessment The questions in this brochure, based on the 2010 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report, 1 are designed to help healthcare professionals (specifically case/care managers)

More information

Pharmacology in the Elderly

Pharmacology in the Elderly Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol

More information

Drugs Categories. 4. Which suffix do alpha blocker generic drug names often end with?

Drugs Categories. 4. Which suffix do alpha blocker generic drug names often end with? CATEGORIES: QUIZ 3 Drugs Categories 1. What drug subcategory often ends with the suffix -azosin? a. Corticosteroids b. Alpha blockers c. Calcium channel blockers d. Beta blockers e. ACE inhibitors 2. What

More information

Preventing Falls in Older Adults A Matter of Safety

Preventing Falls in Older Adults A Matter of Safety Preventing Falls in Older Adults A Matter of Safety Roger Tam, BSc. Pharm. Wal-Mart Clinical Designated Pharmacist Falls Prevention Pharmacist Specialist NCCHC-Pre/Post Test Educator Q.U.I.T Educator Overview

More information

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Drugs in Older Adults: Beers Criteria Heather Sakely,

More information

David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care

David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care Geriatrics Clinic- Providence VAMC VA Grand Rounds

More information

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor

More information

Intelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork

Intelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork Intelligent Polypharmacy Professor Colin P Bradley Department of General Practice University College Cork Polypharmacy No standard definition 2005 review the use of medications that are not clinically

More information

Polypharmacy and the Geriatric: A Bag Full of Pills. Daria C. Ruffolo DNP, RN CCRN Acute Care Nurse Practitioner

Polypharmacy and the Geriatric: A Bag Full of Pills. Daria C. Ruffolo DNP, RN CCRN Acute Care Nurse Practitioner Polypharmacy and the Geriatric: A Bag Full of Pills Daria C. Ruffolo DNP, RN CCRN Acute Care Nurse Practitioner druffol@lumc.edu 708-216-4541 There Are No Conflicts of Interests Overview Definitions and

More information

CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS

CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS 1. The following is an accurate description of the aging population: A. The number of older adults will reach 17 million in 2030 B. The ratio of women to

More information

Katee Kindler, PharmD, BCACP

Katee Kindler, PharmD, BCACP Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,

More information

Prescribing Dilemmas. Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May

Prescribing Dilemmas. Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May Prescribing Dilemmas Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May 2016 The four principles of medicines optimisation Aim to understand the patient s experience Evidence

More information

Study Guidelines for Quiz #1

Study Guidelines for Quiz #1 Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing

More information

Quality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Quality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety Quality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

Prescribing Drugs to the Elderly

Prescribing Drugs to the Elderly Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering

More information

How to Teach About Drugs and Aging

How to Teach About Drugs and Aging How to Teach About Drugs and Aging Brandon Koretz MD Assistant Clinical Professor Division of Geriatrics Challenges Prescription pad:internist::scalpel: Surgeon Artificial split between theory and practice

More information

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017 Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017 Disclosure I have no current affiliation or financial arrangement with any grantor or commercial

More information

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017 What is Polypharmacy Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017 The use of multiple medications simultaneously Rx OTC Herbal Disclosure

More information

Definition and Statistics

Definition and Statistics Objectives 1. Describe the basic principles of how drugs work in the body and with one another. Nanette R Wrobel, RPh Director of Education/Clinical Director Pharmacy Alternatives 2. Identify the four

More information

Workshop 4: Preventing Falls through Medication Vigilance

Workshop 4: Preventing Falls through Medication Vigilance Workshop 4: Preventing Falls through Medication Vigilance Nancy L. Losben, R.Ph., CCP, FASCP, CG Chief Quality Officer Omnicare, Inc. & Diane C. Vaughn, RN, C-DONA/LTC, LNHA VP, Clinical Services Benedictine

More information

Deprescribing Unnecessary Medications: A Four-Part Process

Deprescribing Unnecessary Medications: A Four-Part Process Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient

More information

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2015 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES REGISTRY ONLY DESCRIPTION:

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS Frequently Asked Questions: Table of Contents How should pain be assessed in an unconscious patient? What is the cardiovascular risk associated with the use of nsnsaids/coxibs

More information

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines

More information

Strategies to manage medication related falls in older people

Strategies to manage medication related falls in older people Strategies to manage medication related falls in older people ALLEN R. HUANG, MDCM, FRCPC RGPEO Refresher Day, April 5, 2017 www.ottawahospital.on.ca Affiliated with Affilié à DISCLOSURES I have no conflict

More information

TOP 5 DRUGS.. TO AVOID IN THE ELDERLY

TOP 5 DRUGS.. TO AVOID IN THE ELDERLY TOP 5 DRUGS.. TO AVOID IN THE ELDERLY Debbie Kwan, BScPhm., MSc., FCSHP Canadian Geriatrics Society, April 20, 2013 Disclosure of Potential for Conflict of Interest: Financial Disclosure: None Mar 26,

More information

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty A Primer on Safe Prescribing to the Elderly Dr. John Puxty Learning Objectives Describe an approach to safe prescribing for older patients. Appreciate the significance and causes of Polypharmacy. Identify

More information

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment

More information

Depression in Late Life

Depression in Late Life Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression

More information

University of Hawaii Center on Aging

University of Hawaii Center on Aging University of Hawaii Center on Aging. Supported in part by a cooperative agreement No. 90AL0011-01-00 from the Administration on Aging, Administration for Community Living, U.S. Department of Health and

More information

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College Prevention of Medication-Related Falls Through Appropriate Medication Use Clay Sprouse, MEd., CPhT Piedmont Technical College Disclosure I have no relevant financial or nonfinancial relationships to disclose

More information

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion

More information

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE Cholinesterase inhibitors and Memantine are now classified as green (following specialist initiation) drugs by the Greater Manchester Medicines Management Group. Who will diagnose and decide who is suitable

More information

Smoking Cessation Pharmacotherapy Guidelines

Smoking Cessation Pharmacotherapy Guidelines Smoking Cessation Pharmacotherapy Guidelines INTRODUCTION This guideline is based on public health guidance 10 Smoking Cessation Services issued by the National Institute for Health and Clinical Excellence

More information

CONTRAINDICATIONS TABLE

CONTRAINDICATIONS TABLE CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis

More information

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015 Calgary Long Term Care Formulary Pharmacy & Therapeutics February 2015 Highlights http://www.albertahealthservices.ca/4070.aspx 1 Contents February 2016... 3 Added Product(s)... 3 Not Listed, Delisted

More information

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Target Audience: Pharmacists ACPE#: 0202-9999-18-056-L01-P Activity Type: Application-based Disclosures Kathleen

More information

Damn it Jim, I m an EMT not a Doctor. EMS Drug-Drug interactions and how not to be the grim reaper

Damn it Jim, I m an EMT not a Doctor. EMS Drug-Drug interactions and how not to be the grim reaper Damn it Jim, I m an EMT not a Doctor EMS Drug-Drug interactions and how not to be the grim reaper OBJECTIVES Examine EMS drugs and the interactions they have with other medications. Describe potential

More information

Medication Management. Medications: The Right Balance. Who are we talking about? Geriatric Syndromes 9/19/2016. Older adults are a heterogenous group!

Medication Management. Medications: The Right Balance. Who are we talking about? Geriatric Syndromes 9/19/2016. Older adults are a heterogenous group! Medication Management Who are we talking about? Older adults are a heterogenous group! Patricia W. Slattum, PharmD, PhD Professor of Pharmacotherapy and Outcomes Science Director, Geriatric Pharmacotherapy

More information

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future Daniel S. Sitar Professor Emeritus University of Manitoba Email: Daniel.Sitar@umanitoba.ca March 6, 2018 INTRODUCTION EPIDEMIOLOGY

More information

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers This formulary is current as of February 11, 2010. Important Notes: Pharmacists must submit a claim on PharmaNet at the time

More information

Medication Management When Caring for Seniors at Home

Medication Management When Caring for Seniors at Home Medication Management When Caring for Seniors at Home White Paper May 24, 2013 2013 Physician s Choice Private Duty http://private-duty.pchhc.com 1 Proper medication management for seniors who live at

More information

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS 1 PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS OBJECTIVES 2 Know and understand: Key issues in geriatric pharmacology Effects of age on pharmacokinetics

More information

Geriatric Medications How Hard Is It?

Geriatric Medications How Hard Is It? Geriatric Medications How Hard Is It? Course ID: 1027 - Credit Hours: 1 Author(s) Bonnie Chustz,RN, BSN WCC Disclosures Insert any affiliations that should be disclosed here. Audience Please insert the

More information

Adverse Drug Events in the Older Adult Population. Alan Lukazewski, RPh, CDE, CGP Oakwood Lutheran Senior Ministries 1

Adverse Drug Events in the Older Adult Population. Alan Lukazewski, RPh, CDE, CGP Oakwood Lutheran Senior Ministries 1 Adverse Drug Events in the lder Adult Population Alan Lukazewski, RPh, CDE, CGP akwood Lutheran Senior Ministries 1 This educational session is possible through the generous support of the Helen Bader

More information

Connecticut Medical Assistance Pharmacy Program Drug Utilization Review (DUR) Program DUR Board Meeting

Connecticut Medical Assistance Pharmacy Program Drug Utilization Review (DUR) Program DUR Board Meeting March 2015 Minutes ATTENDEES Board Members Present: Kenneth Fisher, R.Ph. (Chair), Keith Lyke R.Ph., Bhupesh Mangla, MD, Richard Gannon, Pharm.D., Charles Caley Pharm.D. BCPP, Ram Illindala, MD, Carol

More information

90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.

90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15. 90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.00 Allergy/Cold&Flu C-Phen Drops n/a Drops 90 $15.00 Allergy/Cold&Flu

More information

Back to Basics: The Basics of Medication Monitoring

Back to Basics: The Basics of Medication Monitoring DIAMOND PHARMACY SERVICES Back to Basics: The Basics of Medication Monitoring Presented by: Dr. Deborah Milito, Pharm. D., CGP. Director of Clinical and Consultant Services Skilled Division Annual Educational

More information

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety

Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2016 PHYSICIAN QUALITY REPORTING OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY DESCRIPTION:

More information

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution

More information

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Rational prescribing in the older adult. Assoc Prof Craig Whitehead Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade

More information

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults CLINICAL INVESTIGATIONS American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults By the American Geriatrics Society 2015 Beers Criteria Update

More information

Beers Criteria: Practical Considerations. A Clinician Education Tool. Curt Wood, RPh, CGP, FASCP

Beers Criteria: Practical Considerations. A Clinician Education Tool. Curt Wood, RPh, CGP, FASCP Beers Criteria: Practical Considerations A Clinician Education Tool Curt Wood, RPh, CGP, FASCP Objectives: u Explain the purpose of the Beers Criteria u Discuss the key concepts in applying the Beers Criteria

More information

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.

More information

Delirium and Dementia

Delirium and Dementia Delirium and Dementia Elder Friendly Care in Acute Care Seniors Health Strategic Clinical Network Acute Care Stress Blender Poor Poor sleep At-Risk Older Adult TREAT CAUSE immediately & aggressively. Increased

More information

Geriatric prescribing considerations

Geriatric prescribing considerations Geriatric prescribing considerations Melanie A. Dodd, Pharm.D., Ph.C., BCPS Associate Professor of Pharmacy in Geriatrics Vice-chair, Department of Pharmacy Practice and Administrative Sciences College

More information

CORVITOL 50mg and 100mg tablets

CORVITOL 50mg and 100mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER CORVITOL 50mg and 100mg tablets METOPROLOL TARTRATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

DRUGS, PREGNECY & NEWBORN

DRUGS, PREGNECY & NEWBORN DRUGS, PREGNANCY & NEWBORN DRUGS, PREGNECY & NEWBORN By- Dr Raghuveer Ist By- PG Dept of Rasashastra Dr Raghuveer Dept of Rasashastra KVG Ayurvedic Medical College Sullia ayuraghu@rediffmail.com Introduction

More information

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax:

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax: Michelle Zetoony, DO, FCCP, FACOI 545 4 th Avenue S, Suite A Phone: 727-826-0933 Fax: 727-826-0744 http://www.dosleep.com SLEEP TALK 9/9 BMJ Open2012 Pharmacology and therapeutics Research What is sleep?

More information

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine A Geriatrician s Perspective on Successful Aging Ariel Green, MD, MPH Assistant Professor of Medicine 1 Disclosures Johns Hopkins Clinical Research Scholars Program American College of Cardiology Foundation

More information

Meds and Falls: Keep in Step with your Meds

Meds and Falls: Keep in Step with your Meds Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu

More information

Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria a population-based cohort study

Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria a population-based cohort study DOI:10.1111/j.1365-2125.2005.02391.x British Journal of Clinical Pharmacology Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria a population-based cohort study Cornelis S.

More information

Identifying Inappropriate Medications and Deprescribing Strategies ANGELA M. HILL, PHARM.D., RCPH GWEP JUNE 9, 2017

Identifying Inappropriate Medications and Deprescribing Strategies ANGELA M. HILL, PHARM.D., RCPH GWEP JUNE 9, 2017 Identifying Inappropriate Medications and Deprescribing Strategies ANGELA M. HILL, PHARM.D., RCPH GWEP LEARN@LUNCH JUNE 9, 2017 Objectives of Talk Identify inappropriate medications in a medication regimen

More information

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS Formulary and Prescribing Guidelines 9.1 Introduction Movement disorders and extrapyramidal side effects can manifest in the

More information

Salicylates: Interactions 10/14/2009. Salicylates DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. Chapters 17, 18, 34 & Pages 577 &

Salicylates: Interactions 10/14/2009. Salicylates DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS. Chapters 17, 18, 34 & Pages 577 & DRUGS USED IN THE MANAGEMENT OF MUSCULOSKELETAL DISORDERS Chapters 17, 18, 34 & Pages 577 & 579-586 Salicylates aspirin Have analgesic, antipyretic, and anti-inflammatory effects. Inhibits the production

More information

Patient Information leaflet

Patient Information leaflet Patient Information leaflet CARDISEC (90 MG, 120 MG AND 180 MG) DILTIAZEM HYDROCHLORIDE PROLONGED- RELEASE CAPSULES USP) Read all of this leaflet carefully before you start taking this medicine because

More information

Elavil (amitriptyline)

Elavil (amitriptyline) Generic name: Amitriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets; 10 mg/ml injection Available in generic: Yes Drug class: Tricyclic antidepressant General Information

More information

Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities

Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities One definition of polypharmacy is using more medications than is medically necessary. However, it can be

More information

Management of Delirium in Hospice Patients

Management of Delirium in Hospice Patients Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying

More information

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS Philip J. Schneider, MS, FASHP The University of Arizona College of Pharmacy Learning Objectives: Describe the medication-use system and all interdependent

More information

Pharmacology. Definitions. Pharmacology Definitions 8/20/2013. Drug:

Pharmacology. Definitions. Pharmacology Definitions 8/20/2013. Drug: Pharmacology Medications and their potential implications in physical therapy Definitions Drug: Any substance that alters physiologic function in the organism, regardless of whether the effect is beneficial

More information